About Enzymit
Enzymit is a company based in Ness Ziona (Israel) founded in 2020 by Dror Baran. Enzymit has raised $15 million across 3 funding rounds from investors including Khosla Ventures, Grove Ventures and First Star Ventures. Enzymit offers products and services including Enzyme Design Platform and Cell-free Production Platform. Enzymit operates in a competitive market with competitors including Citrine Informatics, Numat, Molecule.one, Kebotix and Chemical.AI, among others.
- Headquarter Ness Ziona, Israel
- Founders Dror Baran
-
Sectors
Chemicals & Materials
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$15 M (USD)
in 3 rounds
-
Latest Funding Round
$10 M (USD), Series A
Sep 25, 2024
-
Investors
Khosla Ventures
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Enzymit
Enzymit offers a comprehensive portfolio of products and services, including Enzyme Design Platform and Cell-free Production Platform.
Uses AI for creating efficient novel enzymes.
Enables cheap and localized bioproduction processes.
People of Enzymit
Unlock access to complete
Unlock access to complete
Funding Insights of Enzymit
Enzymit has successfully raised a total of $15M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $10 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Enzymit
Enzymit has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Khosla Ventures, Grove Ventures and First Star Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Early-stage startups are funded by this venture capital firm.
|
Locked | Locked | Locked | |
|
Investments in technology startups are made by First Star Ventures.
|
Locked | Locked | Locked |
Investor details for Enzymit
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Enzymit
Investment portfolio details for Enzymit
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Enzymit
Detailed financials for Enzymit
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Enzymit Comparisons
Peer comparison for Enzymit
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Enzymit
Enzymit operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Citrine Informatics, Numat, Molecule.one, Kebotix and Chemical.AI, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of AI-based solutions for materials informatics
|
|
| Locked | Locked | Locked |
Provider of chemical packaging, protection & separation services
|
|
| Locked | Locked | Locked |
AI-based software for molecule drug design and synthesis is provided.
|
|
| Locked | Locked | Locked |
AI solutions for materials discovery
|
|
| Locked | Locked | Locked |
Provider of AI-based chemical synthesis and medicinal analysis platform for researchers
|
Detailed competitors of Enzymit
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Enzymit
Complete news archive for Enzymit
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Enzymit
Enzymit was founded in 2020.
Enzymit is headquartered in Ness Ziona, Israel. It is registered at Ness Ziona, Central District, Israel.
Enzymit is a funded company, having raised a total of $15M across 3 funding rounds to date.
Enzymit was founded in 2020 and is based in Ness Ziona, Israel. Operations focus on the biotechnology sector, where computational algorithms are developed to design enzymes. Proprietary tools are utilized for high-throughput enzyme production, and collected data is integrated into deep learning models to enable ongoing optimization of enzyme designs. Services support enzyme engineering for various applications.
Enzymit's top competitors include Citrine Informatics, Numat and Molecule.one.
Enzymit offers Enzyme Design Platform and Cell-free Production Platform.
Enzymit has 5 investors. Key investors include Khosla Ventures, Grove Ventures, First Star Ventures, Sapir Venture Partners, and MassChallenge.